Mutants which acquired resistance to FR-31564 were also resistant to fosfomycin and vice versa. Some exceptions to cross-resistance were found among clinical isolates of certain species.
FR-31564 was found to be incorporated into bacterial cells more efficiently than fosfomycin although the extent of incorporation varied among species. In particular, the uptake rate of FR-31564 by a strain of Pseudomonas aeruginosa was ten times that of fosfomycin.
The uptake rate of FR-31564 by both FR-31564-and fosfomycin-resistant Mutants was less than one-tenth of that by the parent strain.
FR 4. Tsolation of FR-31564-and fosfomycin-resistant mutants The following alternative methods were used for the isolation of the resistant mutants.
(a) When the in vitro antibiotic susceptibility was determined by the agar dilution method, a spot of approximately 103 parent cells was inoculated on an agar plate containing half the minimum inhibitory concentration of the antibiotic. After incubation, the colonies on the plate which were approximately the same in size as the parent colonies were few (< 10). These colonies were picked up and tested for the antibiotic susceptibility. Cells inhibited only at more than 4 times the concentrations for the parent strains were regarded as resistant mutants.
(b) An overnight culture of the test strain in nutrient broth was spread on the nutrient agar containing 400,ug/ml of the test antibiotic to make the population of 105 ~ 107 cells per agar plate. After incubation at 37°C for 20 hours, eighty colonies grown on the plate containing the appropriate number of colonies (102 -103 cells per plate) were picked up randomly as resistant mutants and used for classification purposes.
Antibiotic assays
The concentrations of FR-31564 and fosfomycin in samples were determined by microbiological assays.
(a) Assay for FR-31564: Assay cultures of E. cloacae ATCC 29893 were grown overnight in nutrient broth (Eiken Chemicals) and inoculated into nutrient agar (Difco) at a concentration of 0.5 %. The agar was thoroughly mixed with the bacterial culture, poured into Petri dishes (80 mm) and allowed to harden. Thick paper discs (8 mm) immersed in the antibiotic solutions were placed on the above plates. After incubation for 20 hours at 37°C, the diameters of the inhibitory zones around the discs were measured. The antibiotic concentration in the sample was determined by a calibration curve prepared using known amounts of antibiotic and the diameter of the resulting inhibition zones.
(b) Assay for fosfomycin: The assay method for fosfomycin was the same as that for FR-31564 except that Proteus sp. MB 838 was used as the assay organism and that the inoculum size was 1.0%.
Measurement of intracellular accumulation of FR-31564 and fosfomycin
The reaction mixture used for uptake of the antibiotics had a final volume of 5.0 ml: 0.5 ml of antibiotic (10 mg/ml), 1.0 ml of cell suspension (approximately 1011 cells/ml) and 3.5 ml of nutrient broth (Difco). The cell suspension was prepared as follows: Cells grown overnight at 37°C in nutrient broth were harvested by centrifugation, washed once and resuspended in the same broth (one-hundredth volume of the original culture). After incubation for 20 minutes at 37°C, the cells were washed twice with 50 mm tris buffer (pH 7.0) by centrifugation at 8,000 g for 5 minutes to remove the antibiotic. The cells were resuspended in the same buffer and sonicated at maximum power for 10 minutes with cooling. Antibiotic concentration in the sonicate was determined by microbiological assay. Uptake of the antibiotic was expressed as ng of incorporated antibiotic per mg of cellular protein. Protein was determined according to the method of LOWRY et al. using bovine serum albumin as the standard8).
7. Test for stability of FR-31564 in culture fluids of resistant mutants FR-31564-resistant mutants of various species were grown overnight at 37°C in heart infusion broth. One ml of the overnight culture was inoculated into 3.5 ml of the broth and incubated at 37°C for 2 hours with shaking. Then, 0.5 ml of FR-31564 solution (200 isg/ml) was added to the incubation mixture. After further incubation at 37°C for 3 and 6 hours, the reaction was stopped by the addition of an equal volume of ethanol. Any precipitate formed was removed by centrifugation. Residual content of FR-31564 in the resultant supernatant was determined by microbiological assay. 8. Examination of carbohydrate utilization of FR-31564-resistant mutants Test strains grown on the master plates were replicated on the minimal agar medium modified from E medium of VOGEL and BONNER9). Minimal medium without carbon sources contained (per liter of distilled water) (NH4)2SO4, I g; KH2PO4, 10 g; MgSO2.7H2O2 0.1 g; and agar, 15 g. pH was adjusted to 7.0 with 10 nt KOH.
Carbohydrates were sterilized independently and added to the medium to give a final concentration of I g per liter. Carbohydrates used were as follows: L-o-glycerophosphate, glucose-6-phosphate, glycerol, L-x-glycerophosphate plus cAMP and glycerol plus cAMP. cAMP was supplemented to give a final concentration of 500/tg/ml.
Results and Discussion
1.
Cross-resistance between FR-31564 and Fosfornycin
Most of the mutants which acquired resistance to FR-31564 were also resistant to fosfomycin.
The converse was also established ( (Table 4) .
These results indicate that FR-31564-resistance in bacteria can result from the lack of transport system for FR-31564, used in common for fosfomycin. Meanwhile, inactivation of FR-31564 was ascertained not to contribute to FR-31564-resistance since only slight inactivation was detected after FR-31564 was incubated at 37°C for 6 hours in the culture broths of FR-31564-resistance mutants (Table 5 ).
Active Transport Systems Common to FR-31564 and Fosfomycin
Fosfomycin has been reported to be incorporated into the bacterial cells by two alternative transport systems, namely, L-x-glycerophosphate (genetic designation glp T) and hexose phosphate transport (uhp) systems (Fig. 2)1) Accordingly, FR-31564-resistant mutants were examined for their lack of these transport sys- Tests were performed as described in the text. Test strain used; P. aeruginosa 5-70. Resistant mutants were isolated as described in the text. Selective concentration of the antibiotic; 400 ug/ml. Abbreviations: ceGP, L-a-glycerophosphate; G6P, glucose-6-phosphate.
*: H , able to grow; -, unable to grow **: number of strains able to grow per number of strains tested . 
